VITILIGO-BEHANDLUNG

European patent · EP2957292 · In force

Register entry

Publication number
EP2957292
Application number
EP15170572
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 27, 2009
Published
Dec 23, 2015
Granted
Dec 13, 2017
Protection ends at the latest
Mar 26, 2029
Next annual fee due
Mar 31, 2027
IPC classes
A61K 38/13 (2006.01)
A61K 38/21 (2006.01)
A61K 38/34 (2006.01)
A61K 9/00 (2006.01)
A61K 31/37 (2006.01)
A61K 31/436 (2006.01)
A61K 31/485 (2006.01)
A61K 31/505 (2006.01)
A61K 31/52 (2006.01)
A61K 31/573 (2006.01)
A61K 31/58 (2006.01)
A61K 45/06 (2006.01)
A61N 5/06 (2006.01)
C07K 14/685 (2006.01)
A61P 17/00 (2006.01)
Priority
AU 2008901461 27.03.2008
Divided from
EP09726233
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Sep 8, 2025

    Transferred

    Owner
    Clinuvel Pharmaceuticals Limited, Level 6, 15 Queen Street, Melbourne, VIC 3000, Australia → CLINUVEL INC., 1825 S. Grant Street, Suite 200, San Mateo, CA 94402, USA

    Published in Swissreg on 08.09.2025

  3. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  4. Apr 23, 2024

    Change

    Published in Swissreg on 23.04.2024

  5. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  6. Feb 23, 2018

    Agent entered

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 23.02.2018

  7. Dec 13, 2017

    Granted

    Published in Swissreg on 13.12.2017

Parties

Inventor

Wolgen, Philippe

Melbourne, Victoria 3000, AU

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.